BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6173558)

  • 1. Natural killing activity and interferon production in multiple sclerosis.
    Zander H; Abb J; Kaudewitz P; Riethmüller G
    Lancet; 1982 Jan; 1(8266):280. PubMed ID: 6173558
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between HLA B7, DR2 and dysfunction of natural- and antibody-mediated cytotoxicity without connection with the deficient interferon production in multiple sclerosis.
    Gyódi E; Benczur M; Pálffy G; Tálas M; Petrányi G; Földes I; Hollán SR
    Hum Immunol; 1982 Jun; 4(3):209-17. PubMed ID: 6181031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of interferon production and natural killing by lymphocytes from multiple sclerosis patients.
    Neighbour PA
    Ann N Y Acad Sci; 1984; 436():181-91. PubMed ID: 6085226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon modulation of natural killer cell activity.
    Perussia B; Santoli D; Trinchieri G
    Ann N Y Acad Sci; 1980; 350():55-62. PubMed ID: 6165304
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interferon-producing and cytotoxic activity of natural killer cells in multiple sclerosis patients].
    Sorokin AM; Koval'chuk LV; Tunkel' OI; Cheknev SB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(2):211-5. PubMed ID: 2437743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic influence on natural cytotoxicity and interferon production in multiple sclerosis studies in monozygotic discordant twins.
    Kaudewitz P; Zander H; Abb J; Ziegler-Heitbrock HW; Riethmüller G
    Hum Immunol; 1983 May; 7(1):51-8. PubMed ID: 6682841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology of multiple sclerosis.
    Oger J; Roos R; Antel JP
    Neurol Clin; 1983 Aug; 1(3):655-79. PubMed ID: 6209537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation between impaired interferon production and natural killer activity of lymphocytes in multiple sclerosis.
    Stöger I; Tálas M; Benczúr M; Gyódi E; Petrányi GG; Pálffy G; Kotsy B
    Arch Virol; 1982; 71(3):259-65. PubMed ID: 6179500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locus of selective depression of human natural killer cells by azathioprine.
    Shih WW; Ellison GW; Myers LW; Durkos-Smith D; Fahey JL
    Clin Immunol Immunopathol; 1982 Jun; 23(3):672-81. PubMed ID: 6180857
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interferon and natural cytotoxicity].
    Skurska Z
    Postepy Hig Med Dosw; 1984; 38(5-6):615-32. PubMed ID: 6085589
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular interactions in the augmentation of human NK activity by interferon.
    Saksela E; Timonen T; Cantell K
    Ann N Y Acad Sci; 1980; 350():102-11. PubMed ID: 6165264
    [No Abstract]   [Full Text] [Related]  

  • 12. Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis.
    Neighbour PA; Grayzel AI; Miller AE
    Clin Exp Immunol; 1982 Jul; 49(1):11-21. PubMed ID: 6181920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of interferon in regulation of cytotoxicity by natural killer cells and macrophages.
    Herberman RB; Ortaldo JR; Djeu JY; Holden HT; Jett J; Lang NP; Rubinstein M; Pestka S
    Ann N Y Acad Sci; 1980; 350():63-71. PubMed ID: 6165306
    [No Abstract]   [Full Text] [Related]  

  • 14. Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity.
    Herberman RR; Ortaldo JR; Bonnard GD
    Nature; 1979 Jan; 277(5693):221-3. PubMed ID: 95205
    [No Abstract]   [Full Text] [Related]  

  • 15. [Symposium on mechanisms of host defense from fundamental and clinical medicine. 2. Role of natural killer (NK) cells and interferon in self-defense mechanisms].
    Kumagai K
    Nihon Naika Gakkai Zasshi; 1984 Dec; 73(12):1747-51. PubMed ID: 6085342
    [No Abstract]   [Full Text] [Related]  

  • 16. Natural killer cell activity in multiple sclerosis.
    Hauser SL; Ault KA; Levin MJ; Garovoy MR; Weiner HL
    J Immunol; 1981 Sep; 127(3):1114-7. PubMed ID: 6167616
    [No Abstract]   [Full Text] [Related]  

  • 17. Demonstration of T-cell and K-cell cytotoxicity against measles-infected cells in normal subjects, multiple sclerosis and subacute sclerosing panencephalitis.
    Ewan PW; Lachmann PJ
    Clin Exp Immunol; 1977 Oct; 30(1):22-31. PubMed ID: 304777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased NK killing in patients with multiple sclerosis: an analysis on the level of the single effector cell in peripheral blood and cerebrospinal fluid in relation to the activity in the disease.
    Merrill J; Jondal M; Seeley J; Ullberg M; Sidén A
    Clin Exp Immunol; 1982 Feb; 47(2):419-30. PubMed ID: 6176377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of primitive cells by natural killer cells.
    Kiessling R; Wigzell H
    Curr Top Microbiol Immunol; 1981; 92():107-23. PubMed ID: 6171383
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural cell-mediated immunity during viral infections.
    Welsh RM
    Curr Top Microbiol Immunol; 1981; 92():83-106. PubMed ID: 6171387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.